# Efficacy of Itopride Versus Metoclopramide in Hospitalized Medicine Patients With High Gastric Residual Volume

> **NCT07031479** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Chulalongkorn University** · enrollment: 86 (estimated)

## Conditions studied

- Feeding Intolerance

## Interventions

- **DRUG:** Itopride HCI 50 mg
- **DRUG:** Metoclopramide 10 mg ampoule

## Key facts

- **NCT ID:** NCT07031479
- **Lead sponsor:** Chulalongkorn University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 86 (ESTIMATED)
- **Last updated:** 2025-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07031479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07031479, "Efficacy of Itopride Versus Metoclopramide in Hospitalized Medicine Patients With High Gastric Residual Volume". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07031479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*